Back
Rhythm Pharmaceuticals Vs. Oklo Industry Stock Comparison
Sell
44
RYTM
Rhythm Pharmaceuticals
Last Price:
$57.75
Seasonality Move:
-17.84%
Buy
58
OKLO
Oklo
Last Price:
$26.13
Seasonality Move:
5.58%
Sell
44
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $60.01. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $60.01The current trend is moderately bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
OKLO Stock Price Chart
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 58.68 | Buy |
Chaikin Money Flow: | 521684 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.4 - 59.28) | Buy |
Bollinger Bands (100): | (47.93 - 58.85) | Buy |
OKLO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.8 | Buy |
Relative Strength Index (14 RSI): | 67.48 | Buy |
Chaikin Money Flow: | -5066862 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.58 - 24.92) | Buy |
Bollinger Bands (100): | (8.31 - 23.07) | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.89 | Buy |
20-day SMA: | 56.78 | Buy |
50-day SMA: | 57.58 | Buy |
200-day SMA: | 47.75 | Buy |
8-day EMA: | 58.34 | Buy |
20-day EMA: | 57.63 | Buy |
50-day EMA: | 56.55 | Buy |
200-day EMA: | 49.05 | Buy |
OKLO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.04 | Buy |
20-day SMA: | 21.95 | Buy |
50-day SMA: | 22.19 | Buy |
200-day SMA: | 12.98 | Buy |
8-day EMA: | 25.78 | Buy |
20-day EMA: | 23.41 | Buy |
50-day EMA: | 20.92 | Buy |
200-day EMA: | 14.74 | Buy |
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and an increase next year of $1.66 per share.
Oklo Earnings Growth & OKLO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.27 per share, and a decrease next year of $0.06 per share.
Rhythm Pharmaceuticals Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Oklo Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |